Regional N-Acetylaspartate Reduction in the Hippocampus Detected With Fast Proton Magnetic Resonance Spectroscopic Imaging in Patients With Alzheimer Disease
Open Access
- 1 May 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 59 (5) , 828-834
- https://doi.org/10.1001/archneur.59.5.828
Abstract
PROTON MAGNETIC resonance spectroscopy (1H-MRS) is a noninvasive method to investigate changes of the tissue metabolite composition in different brain diseases. At long echo times (TE >100 milliseconds), the resonance lines of the N-acetyl groups, mainly N-acetylaspartate (NAA), total choline-containing compounds (Cho), and total creatine (tCr), including phosphocreatine and creatine, can be detected. N-acetylaspartate is only located in neurons1 and represents a marker for neuronal integrity. A reduction of NAA has been reported in various brain regions in Alzheimer disease (AD)2 and other neurodegenerative disorders.3-5 Choline-containing compounds represent a constituent of cell membrane metabolism and have been found to be elevated in AD in some6-10 but not all studies.11-18 Total creatine, which is engaged in the cell's energy metabolism, has been reported to remain stable in AD10,19 and other neurodegenerative disorders.20,21 Changes of NAA and Cho are therefore commonly assessed in relation to tCr.Keywords
This publication has 21 references indexed in Scilit:
- Proton Magnetic Resonance Spectroscopy in Kennedy SyndromeArchives of Neurology, 1999
- In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.Archives of General Psychiatry, 1999
- Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.Radiology, 1997
- PROTON MAGNETIC RESONANCE SPECTROSCOPY IN DEMENTIA OF ALZHEIMER TYPEInternational Journal of Geriatric Psychiatry, 1997
- Regional Gray and White Matter Metabolite Differences in Subjects With AD, With Subcortical Ischemic Vascular Dementia, and Elderly Controls With 1H Magnetic Resonance Spectroscopic ImagingArchives of Neurology, 1996
- Nuclear magnetic resonance spectroscopy: A review of neuropsychiatric applicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1995
- Abnormal cerebral metabolite concentrations in patients with probable alzheimer diseaseMagnetic Resonance in Medicine, 1994
- Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.Radiology, 1993
- In vivo quantification of brain metabolites by 1H-MRS using water as an internal standardMagnetic Resonance Imaging, 1993
- Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In VitroJournal of Neurochemistry, 1992